FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2621051394> ?p ?o ?g. }

• W2621051394 endingPage "4340" @default.
• W2621051394 startingPage "4331" @default.
• W2621051394 abstract "ABSTRACT Although aberrant androgen receptor (AR) signaling is a central mechanism for castration resistant prostate cancer (CRPC) progression, AR‐independent growth signaling is also present in CRPC. The current therapeutic options for patients with CRPC are limited and new drugs are desperately needed to eliminate these crucial growth signaling pathways. We have previously shown that combination of carmustine and selenite effectively induces apoptosis and growth inhibition by targeting AR and AR‐variants in CRPC cells. High levels of EGFR expression present in the CRPC cells mediates the cell proliferation via AR‐independent growth signaling mechanisms. Therefore, in this study, we investigated whether the combination of carmustine and selenite could inhibit EGFR mediated growth signaling and induce apoptosis in androgen independent‐AR negative prostate cancer cells. EGF exposure dose and time dependently increased phospho‐EGFR (Tyr845, Tyr1068, and Tyr1045), pAkt (Ser473), and pERK1/2 (Thr204/Tyr202) protein expression levels in AIPC cells. Combination of carmustine and selenite treatment markedly suppressed EGF‐stimulated proliferation and survival of AIPC cells and effectively induced apoptosis. The ROS generated by the combination of carmustine and selenite exhibited a strong inhibition on EGF stimulated EGFR and its downstream signaling molecules such as Akt, NF‐kB, ERK1/2, and Cyclin D1. Individual agent treatment showed only partial effect. Overall, our findings demonstrated that the combination of carmustine and selenite treatment dramatically inhibits EGFR signaling, proliferation, and induces apoptosis in AIPC cells, suggesting a potential candidate for the treatment of CRPC. The results of the study further suggest that the combination of carmustine and selenite treatment can overcome EGFR mediated AR‐independent growth response in CRPC during anti‐androgen therapy. J. Cell. Biochem. 118: 4331–4340, 2017. © 2017 Wiley Periodicals, Inc." @default.
• W2621051394 created "2017-06-09" @default.
• W2621051394 creator A5016778360 @default.
• W2621051394 creator A5046280416 @default.
• W2621051394 creator A5057878566 @default.
• W2621051394 creator A5081119848 @default.
• W2621051394 creator A5082058711 @default.
• W2621051394 date "2017-05-25" @default.
• W2621051394 modified "2023-10-18" @default.
• W2621051394 title "Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen‐Independent Prostate Cancer Cells" @default.
• W2621051394 cites W1528881540 @default.
• W2621051394 cites W1617532721 @default.
• W2621051394 cites W1964280812 @default.
• W2621051394 cites W1965627667 @default.
• W2621051394 cites W1967394241 @default.
• W2621051394 cites W1976731794 @default.
• W2621051394 cites W1983668987 @default.
• W2621051394 cites W1990338625 @default.
• W2621051394 cites W1995492935 @default.
• W2621051394 cites W1996598972 @default.
• W2621051394 cites W2002232322 @default.
• W2621051394 cites W2004361934 @default.
• W2621051394 cites W2005958584 @default.
• W2621051394 cites W2018711510 @default.
• W2621051394 cites W2025336062 @default.
• W2621051394 cites W2042382433 @default.
• W2621051394 cites W2048988434 @default.
• W2621051394 cites W2053008501 @default.
• W2621051394 cites W2057458801 @default.
• W2621051394 cites W2058112104 @default.
• W2621051394 cites W2059944478 @default.
• W2621051394 cites W2062289724 @default.
• W2621051394 cites W2062657417 @default.
• W2621051394 cites W2075014972 @default.
• W2621051394 cites W2085617376 @default.
• W2621051394 cites W2088277062 @default.
• W2621051394 cites W2096909126 @default.
• W2621051394 cites W2110534364 @default.
• W2621051394 cites W2120760291 @default.
• W2621051394 cites W2133328496 @default.
• W2621051394 cites W2144169031 @default.
• W2621051394 cites W2144486277 @default.
• W2621051394 cites W2148643283 @default.
• W2621051394 cites W2153540002 @default.
• W2621051394 cites W2165300664 @default.
• W2621051394 cites W2405066569 @default.
• W2621051394 doi "https://doi.org/10.1002/jcb.26086" @default.
• W2621051394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28430389" @default.
• W2621051394 hasPublicationYear "2017" @default.
• W2621051394 type Work @default.
• W2621051394 sameAs 2621051394 @default.
• W2621051394 citedByCount "10" @default.
• W2621051394 countsByYear W26210513942017 @default.
• W2621051394 countsByYear W26210513942018 @default.
• W2621051394 countsByYear W26210513942019 @default.
• W2621051394 countsByYear W26210513942021 @default.
• W2621051394 countsByYear W26210513942022 @default.
• W2621051394 countsByYear W26210513942023 @default.
• W2621051394 crossrefType "journal-article" @default.
• W2621051394 hasAuthorship W2621051394A5016778360 @default.
• W2621051394 hasAuthorship W2621051394A5046280416 @default.
• W2621051394 hasAuthorship W2621051394A5057878566 @default.
• W2621051394 hasAuthorship W2621051394A5081119848 @default.
• W2621051394 hasAuthorship W2621051394A5082058711 @default.
• W2621051394 hasConcept C121608353 @default.
• W2621051394 hasConcept C126322002 @default.
• W2621051394 hasConcept C170493617 @default.
• W2621051394 hasConcept C185592680 @default.
• W2621051394 hasConcept C190283241 @default.
• W2621051394 hasConcept C2776694085 @default.
• W2621051394 hasConcept C2778119113 @default.
• W2621051394 hasConcept C2779438470 @default.
• W2621051394 hasConcept C2779707156 @default.
• W2621051394 hasConcept C2780147359 @default.
• W2621051394 hasConcept C2780192828 @default.
• W2621051394 hasConcept C502942594 @default.
• W2621051394 hasConcept C55493867 @default.
• W2621051394 hasConcept C61367390 @default.
• W2621051394 hasConcept C62112901 @default.
• W2621051394 hasConcept C62478195 @default.
• W2621051394 hasConcept C71924100 @default.
• W2621051394 hasConcept C75217442 @default.
• W2621051394 hasConcept C86803240 @default.
• W2621051394 hasConcept C98274493 @default.
• W2621051394 hasConceptScore W2621051394C121608353 @default.
• W2621051394 hasConceptScore W2621051394C126322002 @default.
• W2621051394 hasConceptScore W2621051394C170493617 @default.
• W2621051394 hasConceptScore W2621051394C185592680 @default.
• W2621051394 hasConceptScore W2621051394C190283241 @default.
• W2621051394 hasConceptScore W2621051394C2776694085 @default.
• W2621051394 hasConceptScore W2621051394C2778119113 @default.
• W2621051394 hasConceptScore W2621051394C2779438470 @default.
• W2621051394 hasConceptScore W2621051394C2779707156 @default.
• W2621051394 hasConceptScore W2621051394C2780147359 @default.
• W2621051394 hasConceptScore W2621051394C2780192828 @default.
• W2621051394 hasConceptScore W2621051394C502942594 @default.
• W2621051394 hasConceptScore W2621051394C55493867 @default.
• W2621051394 hasConceptScore W2621051394C61367390 @default.

• next